PREBOOST® is a new, proprietary over-the-counter (OTC) male genital desensitizer that helps in temporarily prolonging the time until ejaculation in men with premature ejaculation.
PREBOOST® is compliant with the relevant FDA monograph and is approved for sale in the United States. PREBOOST® is the only individually packaged medicated wipe that contains a desensitizing agent (benzocaine 4.0%). Unlike currently available OTC desensitizing sprays or gels that contain lidocaine or benzocaine, PREBOOST® is an individually packaged wipe containing 4% benzocaine, which allows for discrete, direct and precise application of the correct dosage each time. It is applied topically and dries quickly which prevents the potential for transference to a partner.
The product is now available and can be purchased through the e-commerce site http://preboost.com. The site includes information about PREBOOST®, including how to apply the product, as well as frequently asked questions (FAQs) and tips for better sex with a partner.
“I invented PREBOOST® to help the millions of men who suffer from PE and for those couples that want to extend their sexual pleasure,” said Dr. Harry Fisch, the Company’s Chief Corporate Officer “We believe PREBOOST® has significant advantages over currently available therapies, especially with regard to ease of use, delivery system and convenience.”
“Premature ejaculation is a large and underserved market,” said Mitchell Steiner, M.D. President and Chief Executive Officer of
“In my opinion, PREBOOST® is the only over-the-counter product that has the clinical data that shows that it prolongs ejaculation time based on an interim analysis of a well-designed placebo controlled study with statistically significant results,” said Ridwan Shabsigh, M.D., Professor of Urology at
As previously announced, the Company reported top line interim analysis of an independent, double-blind, randomized, controlled clinical study of PREBOOST®. The scientific abstract that describes the full interim analysis results has been submitted to a major urological medical conference.
The independent clinical study was conducted by Jed Kaminetsky, M.D., Medical Director at
The top line results of the interim analysis from 21 men show:
The Company said the interim results in men with PE show that PREBOOST® prolonged time to ejaculation in men who suffer from PE.
About Premature Ejaculation (PE):
PREBOOST® is now available and can be purchased through the e-commerce site http://preboost.com.
More information about the
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:
Contact: Kevin Gilbert 312-366-2633
Press Release Kari Sharp